SCHEMBL31155292

SCHEMBL31155292

Cc1ccc(CN2CCN(C(=O)OC(C)(C)C)C[C@@H]2C)nn1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ GPR119 Q8TDV5 13/20 0.44
▸ SMARCA2 P51531 1/20 0.42
▸ SMARCA4 P51532 1/20 0.42
▸ PBRM1 Q86U86 1/20 0.42
▸ TBK1 Q9UHD2 1/20 0.41
▸ SETD7 Q8WTS6 1/20 0.40
▸ BRD4 O60885 1/20 0.39
▸ KDM1A O60341 1/20 0.38
▸ TUBB4A P04350 1/20 0.38
▸ TUBB P07437 1/20 0.38
▸ TUBA3C P0DPH7 1/20 0.38
▸ TUBA1B P68363 1/20 0.38
▸ TUBA4A P68366 1/20 0.38
▸ TUBB4B P68371 1/20 0.38
▸ TUBB3 Q13509 1/20 0.38
▸ TUBB2A Q13885 1/20 0.38
▸ TUBB8 Q3ZCM7 1/20 0.38
▸ TUBA3E Q6PEY2 1/20 0.38
▸ TUBA1A Q71U36 1/20 0.38
▸ KDM1B Q8NB78 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29232262 0.83 SMARCA2 (0.43) GPR119SMARCA2SMARCA4PBRM1TBK1
SCHEMBL29232489 0.83 SMARCA2 (0.43) GPR119SMARCA2SMARCA4PBRM1TBK1
SCHEMBL30163915 0.83 SMARCA2 (0.43) GPR119SMARCA2SMARCA4PBRM1TBK1
SCHEMBL30163944 0.83 SMARCA2 (0.43) GPR119SMARCA2SMARCA4PBRM1TBK1
SCHEMBL30163935 0.83 SMARCA2 (0.43) GPR119SMARCA2SMARCA4PBRM1TBK1
SCHEMBL29232251 0.81 GPR119 (0.46) GPR119SMARCA2SMARCA4PBRM1TBK1
SCHEMBL30918491 0.80 GPR119 (0.48) GPR119SMARCA2SMARCA4PBRM1TBK1
SCHEMBL9963100 0.80 GPR119 (0.48) GPR119SMARCA2SMARCA4PBRM1TBK1
SCHEMBL9963102 0.80 GPR119 (0.48) GPR119SMARCA2SMARCA4PBRM1TBK1
SCHEMBL30774994 0.79 GPR119 (0.47) GPR119SMARCA2SMARCA4PBRM1TBK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024199402-A1 HETEROCYCLIC COMPOUND AS AT2R ANTAGONIST 武汉人福创新药物研发中心有限公司 2024-10-03 — — WO disclosed
CN-118724877-A Heterocyclic compounds as AT2R antagonists 武汉人福创新药物研发中心有限公司 2024-10-01 — — CN disclosed
Send feedback